Implementation Services

DermatologyGastroenterolgyUrologyHematologyTechnology

Our implementation process is the most robust and cost effective.

Miraca Life Sciences has the experience your practice needs. You don't need to be the expert—we'll be your expert.

Preparation

Clients receive full-service system management, complete with a pre-configured, all-inclusive system backed by a Miraca support team. Hardware is warrantied and customized to individual practices, and there is no need to train staff, or hire additional staff, to run IT. Miraca's implementation process allows you to focus on being a physician, taking time and stress away from grappling with equipment.

  • GAP analysis
  • Seamless interfaces
  • Paperless integration
  • Maximization your system and process efficiency
  • Customized content
  • Comprehensive reporting abilities

Implementation

Our expert team is deployed to your practice during and after installation to help prepare your staff. You will have a trusted person, familiar to your team and practice, providing a personalized training program and project management. Your bi-directional pathology interface is live on day 1, providing supplementary data, electronic results, and improved workflow, resulting in a more accurate, comprehensive diagnosis.

  • Assigned trainer throughout process
  • Customized training to meet your workflow needs
  • On-site training and access to materials
  • Dedicated Account Technical Manager

Support

Our goal is to empower you to operate your practice self-sufficiently. But Miraca Life Sciences experts are never far away. For the first full week, a technician and trainer are onsite, working side-by-side with your staff. Future updates? We have you covered. Our team upgrades, updates, and supports hardware and software.

  • On-site technician
  • Phone support
  • Dedicated Account Services Manager
  • Hardware upgrades
  • Update/upgrade management

Contact Miraca Life Sciences to learn how Miraca can assist your practice
Call 1.866.588.3280 or email MiracaTechnology@MiracaLS.com

Choose Miraca for Your Patients


Learn more about Miraca's Anatomic Pathology services

Learn More »

Miraca’s pathologists have been equally diligent with regard to tailoring their reports to the specifications of each of our physicians. They return reports in a timely fashion, communicate their concerns quickly and have excellent provider support.
— Martha J. Maso, MD, MPH,
Dermatologist, Westwood Dermatology Group, Westwood, N.J.


READ MORE
Learn about Miraca's unmatched quality. We provide our clients with access to the highest quality AP services.

Recent News


May 22, 2017

Miraca Life Sciences Again Expands Therapeutic Drug Monitoring with Addition of First Biosimilar Inflectra®

IRVING, Texas, May 23, 2017 — Miraca Life Sciences, the largest U.S. independent anatomic pathology laboratory, has further expanded its InformTx™ therapeutic drug monitoring (TDM) capabilities with the addition of testing for Inflectra® (infliximab-dyyb), which is the first biosimilar drug in the test offering. Since launching InformTx in June 2016, Miraca Life Sciences has expanded the service from four to […]

Continue reading


April 18, 2017

Miraca Research News: Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US

Pathologists at Miraca Life Sciences contributed significantly in the development of a new product from Philips, the IntelliSite Pathology Solution. As one of four clinical study sites, Miraca Life Sciences participated in “one of the largest studies ever conducted to directly compare the use of digital pathology to optical microscopes.” At Miraca, participation in the Philips study was a project of Miraca […]

Continue reading


April 11, 2017

Ten Research Projects from Miraca Life Sciences Accepted for DDW Conference

IRVING, Texas, April 12, 2017 — Ten research projects from the GI pathologists at Miraca Life Sciences, the nation’s largest independent anatomic pathology lab, have been accepted for presentation at the Digestive Disease Week® conference (DDW), which will be held May 6–9 in Chicago. DDW is the world’s largest gathering of physicians, researchers and industry in the fields of gastroenterology, […]

Continue reading


March 27, 2017

Simponi® is Sixth Drug in InformTx™ Therapeutic Drug Monitoring Service from Miraca Life Sciences

IRVING, Texas, March 28, 2017 — Miraca Life Sciences, the largest U.S. independent anatomic pathology laboratory, continues to expand its InformTx™ therapeutic drug monitoring (TDM) capabilities, now testing for Simponi (golimumab) as well as patient-developed antibodies to Simponi. This is the first TDM assay available in the United States for Simponi. With this addition, Miraca Life Sciences now performs TDM […]

Continue reading


November 30, 2016

Stelara® Now Available for Therapeutic Drug Monitoring from Miraca Life Sciences

IRVING, Texas, December 1, 2016 — Miraca Life Sciences, the largest U.S. independent anatomic pathology lab, has expanded its InformTx™ therapeutic drug monitoring service for drugs that treat inflammatory bowel disease (IBD) with the addition of Stelara (ustekinumab).

Miraca Life Sciences continues to perform therapeutic drug monitoring (TDM) for Remicade® (infliximab), Humira® (adalimumab), Cimzia® (Certolizumab pegol) and Entyvio® (vedolizumab). Since […]

Continue reading